Ponatinib / AP24534 / 943319-70-8

• Post Date:

  Aug 18,2016

• Expiry Date:

  Aug 18,2017

• Detailed Description:

  Cas No. :943319-70-8 Specs:98%min
  Payment Method: T/T
  Ponatinib is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor.Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.

• CAS Registry Number:

  943319-70-8

• Synonyms:

  ;AP24534;AP24534(Ponatinib);

• Molecular Formula:

  C₂₉H₂₇F₃N₆O

• Molecular Weight:

  532.5595

• Molecular Structure:

  

• Company:

  Shanghai Biopharmaleader Co.,Ltd     [ China ]        

• Contact:

  Brenda Xu

• Tel:

  021-50180596

• Fax:

  021-57758967

• Email:

  brenda@biopharmaleader.com